Remove tag digital-health-funding
article thumbnail

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

Associate Professor, Global Health. There is a national priority to increase diversity in clinical trials, from regulatory, funding agencies, industry, and others, so that the participant population reflects the U.S. Associate Professor with Tenure, Medicine. Duke University School of Medicine. Michelle Kelsey, MD. Key Points.

article thumbnail

Predicting pandemics with unconventional digital tools

pharmaphorum

The world is awash with data, and while retailers and TV subscription services have perfected the art of collection and curation, public health has been trailing behind. Prof Brownstein, who is also chief innovation officer at Boston Children’s Hospital, said: “COVID-19 has put a real focus on the inadequacies of public health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patient adherence – the key to restoring trust in pharma

pharmaphorum

This lack of trust in such a crucial industry can lead to decreased compliance, poor treatment adherence, and negative health outcomes for patients. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. Pharma’s bottom line will improve.

article thumbnail

New Rare Disease Drugs and Research Advancements

XTalks

Despite high price tags of a couple of million dollars, gene therapy makers say they are working to ensure patients are able to access the treatments through patient assistance programs developed in conjunction with the support of governments. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.

article thumbnail

Life Sciences 2022 Year in Review

XTalks

As the world continues to experience the effects and aftermath of the COVID-19 pandemic, lessons learned from the biggest global health crisis in recent times spurred changes and adaptations in the life sciences and healthcare. Here are some of the top life science trends and topics from 2022. Gene Therapy Approvals.

article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

The editor of digital health’s newest journal wants to democratize medicine with data ( STAT ). Day One pivots to an IPO for more funding to back its work in pediatric cancer ( Endpoints ). Inside Vida Health’s $110M Series D & Big Push into Digital Mental Health ( The Health Care Blog ).